MedTrace Logo

Bone Marrow Aspirate Concentrate for Anterior Cruciate Ligament Tear Treatment.

NCT06353503 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-08-07

No results posted yet for this study

Summary

A single armed multicenter study enrolling 20 patients using autologous bone marrow aspirate concentrate (which is done under local or general anesthesia to aspirate around 1-2 cc/kg body weight then concentration which is done by using centrifugation and special disposable kit) local injection of 4 cc per joint under ultrasonic guidance ,completely sterile field with local anesthesia.

Conditions

  • Anterior Cruciate Ligament Tear

Interventions

PROCEDURE

autologous bone marrow aspirate concentrate

local knee joint injection of autologous bone marrow

Sponsors & Collaborators

  • abdulmajeed hammadi

    lead INDUSTRY

Principal Investigators

  • abdulmajeed a hammadi, MD · clinical stem cell studies

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-02
Primary Completion
2026-09-27
Completion
2026-09-27

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06353503 on ClinicalTrials.gov